Prediction of Mortality Using Different COPD Risk Assessments – A 12-Year Follow-Up

References

• Backman H, Eriksson B, Ronmark E, et al. Decreased prevalence of moderate to severe COPD over 15 years in northern Sweden. Respir Med. 2016;114:103–110. doi:10.1016/j.rmed.2016.03.013
   PubMed Web of Science ®Google Scholar
• Stallberg B, Janson C, Johansson G, et al. Management, morbidity and mortality of COPD during an 11-year period: an observational retrospective epidemiological register study in Sweden (PATHOS). Prim Care Respir J. 2014;23(1):38–45. doi:10.4104/pcrj.2013.00106
   PubMedGoogle Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-0
   PubMed Web of Science ®Google Scholar
• Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121(5):1434–1440. doi:10.1378/chest.121.5.1434
   PubMed Web of Science ®Google Scholar
• Sundh J, Janson C, Lisspers K, Montgomery S, Stallberg B. Clinical COPD Questionnaire score (CCQ) and mortality. Int J Chron Obstruct Pulmon Dis. 2012;7:833–842. doi:10.2147/COPD.S38119
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.040527
   PubMed Web of Science ®Google Scholar
• Mattila T, Vasankari T, Kanervisto M, et al. Association between all-cause and cause-specific mortality and the GOLD stages 1–4: a 30-year follow-up among Finnish adults. Respir Med. 2015;109(8):1012–1018. doi:10.1016/j.rmed.2015.06.002
   PubMed Web of Science ®Google Scholar
• Celli BR. Predictors of mortality in COPD. Respir Med. 2010;104(6):773–779. doi:10.1016/j.rmed.2009.12.017
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–555. doi:10.1164/rccm.200703-456SO
   PubMed Web of Science ®Google Scholar
• Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP
   PubMed Web of Science ®Google Scholar
• van der Molen T, Willemse BW, Schokker S, Ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1:13. doi:10.1186/1477-7525-1-13
   PubMedGoogle Scholar
• Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586. doi:10.1136/thx.54.7.581
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.00102509
   PubMed Web of Science ®Google Scholar
• Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med. 2012;186(10):975–981. doi:10.1164/rccm.201207-1299OC
   PubMed Web of Science ®Google Scholar
• Dusser D, Wise RA, Dahl R, et al. Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR ((R)) trial. Int J Chron Obstruct Pulmon Dis. 2016;11:133–145. doi:10.2147/COPD.S97924
   PubMed Web of Science ®Google Scholar
• Soriano JB, Alfageme I, Almagro P, et al. Distribution and prognostic validity of the new global initiative for chronic obstructive lung disease grading classification. Chest. 2013;143(3):694–702. doi:10.1378/chest.12-1053
   PubMed Web of Science ®Google Scholar
• Soriano JB, Lamprecht B, Ramirez AS, et al. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data. Lancet Respir Med. 2015;3(6):443–450. doi:10.1016/S2213-2600(15)00157-5
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD Executive Summary Am j Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
   PubMed Web of Science ®Google Scholar
• Criner RN, Labaki WW, Regan EA, et al. Mortality and exacerbations by global initiative for chronic obstructive lung disease groups ABCD: 2011 versus 2017 in the COPD Gene (R) cohort. Chronic Obstr Pulm Dis. 2019;6(1):64–73. doi:10.15326/jcopdf.6.1.2018.0130
   PubMed Web of Science ®Google Scholar
• Gedebjerg A, Szepligeti SK, Wackerhausen LH, et al. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new global initiative for chronic obstructive lung disease 2017 classification: a cohort study. Lancet Respir Med. 2018;6(3):204–212. doi:10.1016/S2213-2600(18)30002-X
   PubMed Web of Science ®Google Scholar
• Le LAK, Johannessen A, Hardie JA, et al. Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort. Int J Chron Obstruct Pulmon Dis. 2019;14:1639–1655. doi:10.2147/COPD.S194019
   PubMed Web of Science ®Google Scholar
• Dijk WD, Bemt L, Haak-Rongen S, et al. Multidimensional prognostic indices for use in COPD patient care. Syst Rev Respir Res. 2011;12:151. doi:10.1186/1465-9921-12-151
   PubMed Web of Science ®Google Scholar
• Jones RC, Donaldson GC, Chavannes NH, et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE index. Am J Respir Crit Care Med. 2009;180(12):1189–1195. doi:10.1164/rccm.200902-0271OC
   PubMed Web of Science ®Google Scholar
• Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet. 2009;374(9691):704–711. doi:10.1016/S0140-6736(09)61301-5
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012. doi:10.1056/NEJMoa021322
   PubMed Web of Science ®Google Scholar
• Sundh J, Janson C, Lisspers K, Stallberg B, Montgomery S. The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD. Prim Care Respir J. 2012;21(3):295–301. doi:10.4104/pcrj.2012.00054
   PubMedGoogle Scholar
• Jones RC, Price D, Chavannes NH, et al. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets. NPJ Prim Care Respir Med. 2016;26:16010. doi:10.1038/npjpcrm.2016.10
   PubMed Web of Science ®Google Scholar
• Morales DR, Flynn R, Zhang J, Trucco E, Quint JK, Zutis K. External validation of ADO, DOSE, COTE and CODEX at predicting death in primary care patients with COPD using standard and machine learning approaches. Respir Med. 2018;138:150–155. doi:10.1016/j.rmed.2018.04.003
   PubMed Web of Science ®Google Scholar
• Puhan MA, Hansel NN, Sobradillo P, et al. Large-scale international validation of the ADO index in subjects with COPD: an individual subject data analysis of 10 cohorts. BMJ Open. 2012;2:6. doi:10.1136/bmjopen-2012-002152
   Web of Science ®Google Scholar
• Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J Suppl. 1993;16:5–40. doi:10.1183/09041950.005s1693
   PubMedGoogle Scholar
• Keene SJ, Jordan RE, Franssen FM, et al. External validation of the updated ADO score in COPD patients from the Birmingham COPD cohort. Int J Chron Obstruct Pulmon Dis. 2019;14:2395–2407. doi:10.2147/COPD.S212381
   PubMed Web of Science ®Google Scholar
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary lung disease 2013. Available from: http://aquirespi.fr/_pages/bpco/doc/gold.pdf?PHPSESSID=g8v35hvk7tb946qmm6nuv8loe0. Accessed December 31, 2013.
   Google Scholar
• Oga T, Tsukino M, Hajiro T, Ikeda A, Nishimura K. Predictive properties of different multidimensional staging systems in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011;6:521–526. doi:10.2147/COPD.S24420
   PubMed Web of Science ®Google Scholar
• Abu Hussein N, Ter Riet G, Schoenenberger L, et al. The ADO index as a predictor of two-year mortality in general practice-based chronic obstructive pulmonary disease cohorts. Respiration Int Rev Thoracic Dis. 2014;88(3):208–214. doi:10.1159/000363770
   Web of Science ®Google Scholar
• Carter JV, Pan J, Rai SN, Galandiuk S. ROC-ing along: evaluation and interpretation of receiver operating characteristic curves. Surgery. 2016;159(6):1638–1645. doi:10.1016/j.surg.2015.12.029
   PubMed Web of Science ®Google Scholar
• Fischer JE, Bachmann LM, Jaeschke R. A readers’ guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med. 2003;29(7):1043–1051. doi:10.1007/s00134-003-1761-8
   PubMed Web of Science ®Google Scholar
• McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax. 2007;62(5):411–415. doi:10.1136/thx.2006.072348
   PubMed Web of Science ®Google Scholar
• Jo YS, Park S, Kim DK, Yoo CG, Lee CH. The cutoff point of clinical chronic obstructive pulmonary disease questionnaire for more symptomatic patients. BMC Pulm Med. 2018;18(1):38. doi:10.1186/s12890-018-0601-0
   PubMedGoogle Scholar
• Sundh J, Stallberg B, Lisspers K, Kampe M, Janson C, Montgomery S. Comparison of the COPD Assessment Test (CAT) and the Clinical COPD Questionnaire (CCQ) in a clinical population. COPD. 2016;13(1):57–65. doi:10.3109/15412555.2015.1043426
   PubMedGoogle Scholar
• Rich JT, Neely JG, Paniello RC, Voelker CC, Nussenbaum B, Wang EW. A practical guide to understanding Kaplan-Meier curves. Otolaryngol–Head Neck Surg. 2010;143(3):331–336. doi:10.1016/j.otohns.2010.05.007
   PubMed Web of Science ®Google Scholar